Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer.
about
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancerRationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancerAdjuvant medical therapy for prostate cancer.Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients.Prostate changes related to therapy: with special reference to hormone therapy.Use of androgen deprivation therapy in prostate cancer: indications and prevalence.Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?Stromal Androgen Receptor in Prostate Cancer Development and ProgressionNeoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.Neoadjuvant systemic therapy for urological malignancies.A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomy.Agonists of luteinizing hormone-releasing hormone in prostate cancer.Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor.Macrocryosectioning and complete sampling of the prostate in a potential multiorgan donor candidate.A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification.Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade.Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.Treatment of locally advanced prostate cancer (Stage T3).Role of bladder neck preservation in urinary continence following radical retropubic prostatectomy.
P2860
Q24244156-6633F810-B496-4627-8006-C6AAD49F6F5BQ27028084-EE851587-2128-46BC-B121-3A845DD5724CQ33758771-A88203F1-49D3-45D3-BFC4-80F3FF0958C3Q35132144-0E184334-B93C-4B52-975D-0C024713F992Q35344149-F2F7F8EC-AC82-4530-8C2F-9D28CEE2983AQ37074379-A8DE0FC4-FA98-469C-AF6D-293CDE0FF030Q37546041-DC0F48E8-6186-4DFD-A3FB-F893437D1508Q37629551-D71FADF0-A201-4C84-8D2B-63CDE319E0ADQ37705424-81B257DB-9C62-44DB-B6D3-8FF6034042A9Q37765651-C339C0A5-757A-47EA-A8C2-4C5E8F1269E8Q38014525-2232B130-2F0C-445D-829C-A48ED88F3738Q38132229-40E7A01B-5900-49FB-BF2B-D97D9D3506D4Q38185175-A9B59BE9-D4F6-4006-BA76-B49DCA92B8CEQ41385564-0F556B00-0353-41D7-9D78-7A56EA3F05C5Q41656689-CD9FA678-1E45-4856-9F00-8FDF9CA72A46Q42400390-86ADD013-772D-4281-AF48-C3C7B31C5737Q44899112-E2C3474F-6F13-486C-A647-5F544743E2E2Q47273306-AC94F353-726F-4147-AF6C-E80ADDFF90E6Q47325983-C7B34AFF-E74D-4F7D-8571-5A88028C4205Q51186040-A03EC50A-0242-4E1E-8EA0-CBEF82132E6BQ53288279-C35380E9-D9C2-4906-BF2A-0F81F793754B
P2860
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Effects of complete androgen b ...... gin status of prostate cancer.
@en
type
label
Effects of complete androgen b ...... gin status of prostate cancer.
@en
prefLabel
Effects of complete androgen b ...... gin status of prostate cancer.
@en
P2093
P2860
P356
P1476
Effects of complete androgen b ...... gin status of prostate cancer.
@en
P2093
A Manganelli
A Santinelli
D Potenzoni
F P Selvaggi
P2860
P304
P356
10.1136/JCP.55.7.508
P407
P577
2002-07-01T00:00:00Z